Carmen Herranz-Ors joined the Translational Cancer Genomics group in March 2020 to work in a project related with of colorectal cancer organoids
My Ph.D. was about the study of a rare disease called Lymphangioleiomyomatosis.
Now, I am working on high-throughput drug screenings in colorectal cancer organoid models to find novel therapies (single compounds or combinations) and biomarkers of response.
Postdoctoral Fellow at the Wellcome Trust Sanger Institute
Graduated from Universitat Pompeu Fabra, Spain, PhD Biomedicine. Title: "Towards improving lymphangioleiomyomatosis care: a study of biomarkers and therapies"
Graduated from Universitat Pompeu Fabra, Spain, MSc Biomedical Research
Graduated from Universitat Autonoma de Barcelona, Spain, BSc Genetics